Tianxin Pharmaceutical: Net profit of 592 million yuan in 2025, down 9.16% year-on-year

Tianxin Pharmaceutical announces that in 2025, operating revenue will be 2.35B yuan, a year-on-year increase of 6.18%. Net profit is 592 million yuan, a decrease of 9.16% year-on-year. The company plans to distribute a cash dividend of 0.55 yuan (tax included) to all shareholders per share, with a total cash dividend distribution of 239 million yuan (tax included).

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin